News + Filings Transactions
|
Sabzevari Helen
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/25/2023 | PRECIGEN, INC. | XON | Sale | Common Stock | 77k | $1.53 | $117.8k | | 08/23/2023 |
| 08/23/2023 | PRECIGEN, INC. | XON | Exercise | Restricted Stock Units | 141.6k | $0.00 | $0 | | 08/23/2023 |
| 08/18/2023 | PRECIGEN, INC. | XON | Sale | Common Stock | 55.9k | $1.66 | $92.7k | | 08/16/2023 |
| 08/16/2023 | PRECIGEN, INC. | XON | Exercise | Restricted Stock Units | 141.6k | $0.00 | $0 | | 08/16/2023 |
| 08/11/2023 | PRECIGEN, INC. | XON | Sale | Common Stock | 41.4k | $1.44 | $59.7k | | 08/09/2023 |
| 08/09/2023 | PRECIGEN, INC. | XON | Exercise | Restricted Stock Units | 141.6k | $0.00 | $0 | | 08/09/2023 |
| 08/04/2023 | PRECIGEN, INC. | XON | Sale | Common Stock | 52.9k | $1.10 | $58.2k | | 08/02/2023 |
| 08/02/2023 | PRECIGEN, INC. | XON | Exercise | Restricted Stock Units | 141.6k | $0.00 | $0 | | 08/02/2023 |
| 04/28/2023 | PRECIGEN, INC. | XON | Grant | Option to Purchase Common Stock (Right to Buy) | 1.7M | $1.21 | $2.1M | | 04/28/2023 |
| 01/27/2023 | PRECIGEN, INC. | XON | Purchase | Common Stock | 22.9k | $1.75 | $40k | | 01/27/2023 |
| 01/04/2023 | PRECIGEN, INC. | XON | Exercise | Restricted Stock Units | 17.7k | $0.00 | $0 | | 01/04/2023 |
| 06/13/2022 | Kinnate Biopharma Inc. | | Grant | Stock Option (right to buy) | 20.2k | $8.38 | $169.7k | | 06/13/2022 |
| 05/13/2022 | PRECIGEN, INC. | XON | Sale | Common Stock | 178k | $1.19 | $210.9k | | 05/12/2022 |
| 05/12/2022 | PRECIGEN, INC. | XON | Exercise | Restricted Stock Units | 340.9k | $0.00 | $0 | | 05/12/2022 |
| 03/18/2022 | PRECIGEN, INC. | XON | Grant | Restricted Stock Units | 340.9k | $0.00 | $0 | | 03/18/2022 |
| 02/02/2022 | PRECIGEN, INC. | XON | Grant | Option to Purchase Common Stock (Right to Buy) | 847k | $2.33 | $2M | | 02/02/2022 |
| 01/05/2022 | PRECIGEN, INC. | XON | Sale | Common Stock | 1.4k | $3.59 | $4.9k | | 01/04/2022 |
| 01/05/2022 | PRECIGEN, INC. | XON | Sale | Common Stock | 5.6k | $3.59 | $20.1k | | 01/04/2022 |
| 01/04/2022 | PRECIGEN, INC. | XON | Exercise | Restricted Stock Units | 17.7k | $0.00 | $0 | | 01/04/2022 |
| 01/03/2022 | PRECIGEN, INC. | XON | Sale | Common Stock | 3.8k | $3.67 | $14.1k | | 01/02/2022 |
| 01/02/2022 | PRECIGEN, INC. | XON | Exercise | Restricted Stock Units | 9.8k | $0.00 | $0 | | 01/02/2022 |
| 07/19/2021 | PRECIGEN, INC. | XON | Sale | Common Stock | 12.5k | $5.43 | $68k | | 07/17/2021 |
| 07/17/2021 | PRECIGEN, INC. | XON | Exercise | Restricted Stock Units | 25k | $0.00 | $0 | | 07/17/2021 |
| 06/24/2021 | Kinnate Biopharma Inc. | | Grant | Stock Option (right to buy) | 40.5k | $24.38 | $987.4k | | 06/24/2021 |
| 05/13/2021 | PRECIGEN, INC. | XON | Sale | Common Stock | 47.4k | $6.40 | $303.6k | | 05/12/2021 |
| 05/12/2021 | PRECIGEN, INC. | XON | Exercise | Restricted Stock Units | 97.3k | $0.00 | $0 | | 05/12/2021 |
| 03/25/2021 | PRECIGEN, INC. | XON | Grant | Restricted Stock Units | 97.3k | $0.00 | $0 | | 03/25/2021 |
| 01/06/2021 | PRECIGEN, INC. | XON | Sale | Common Stock | 260k | $8.92 | $2.3M | | 01/05/2021 |
| 01/05/2021 | PRECIGEN, INC. | XON | Exercise | Restricted Stock Units | 500k | $0.00 | $0 | | 01/05/2021 |
| 01/04/2021 | PRECIGEN, INC. | XON | Sale | Common Stock | 5.3k | $10.16 | $53.6k | | 01/02/2021 |
| 01/02/2021 | PRECIGEN, INC. | XON | Exercise | Restricted Stock Units | 9.8k | $0.00 | $0 | | 01/02/2021 |
| 07/20/2020 | PRECIGEN, INC. | XON | Sale | Common Stock | 12.2k | $4.58 | $56k | | 07/17/2020 |
| 07/17/2020 | PRECIGEN, INC. | XON | Exercise | Restricted Stock Units | 25k | $0.00 | $0 | | 07/17/2020 |
| 05/15/2020 | PRECIGEN, INC. | XON | Sale | Common Stock | 217.5k | $2.37 | $515.8k | | 05/14/2020 |
| 05/14/2020 | PRECIGEN, INC. | XON | Exercise | Restricted Stock Units | 500k | $0.00 | $0 | | 05/14/2020 |
|
|